LU86421A1 - Derives de piperazine 1,4-disubstitues,composition pharmaceutique les contenant;leur procede d'obtention - Google Patents

Derives de piperazine 1,4-disubstitues,composition pharmaceutique les contenant;leur procede d'obtention Download PDF

Info

Publication number
LU86421A1
LU86421A1 LU86421A LU86421A LU86421A1 LU 86421 A1 LU86421 A1 LU 86421A1 LU 86421 A LU86421 A LU 86421A LU 86421 A LU86421 A LU 86421A LU 86421 A1 LU86421 A1 LU 86421A1
Authority
LU
Luxembourg
Prior art keywords
compound
formula
pyridin
piperazinyl
thieno
Prior art date
Application number
LU86421A
Other languages
English (en)
French (fr)
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of LU86421A1 publication Critical patent/LU86421A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
LU86421A 1985-05-06 1986-05-05 Derives de piperazine 1,4-disubstitues,composition pharmaceutique les contenant;leur procede d'obtention LU86421A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73120185A 1985-05-06 1985-05-06
US73120185 1985-05-06

Publications (1)

Publication Number Publication Date
LU86421A1 true LU86421A1 (fr) 1986-12-05

Family

ID=24938510

Family Applications (1)

Application Number Title Priority Date Filing Date
LU86421A LU86421A1 (fr) 1985-05-06 1986-05-05 Derives de piperazine 1,4-disubstitues,composition pharmaceutique les contenant;leur procede d'obtention

Country Status (25)

Country Link
JP (1) JPH0753728B2 (es)
KR (1) KR940000829B1 (es)
CN (1) CN1017901B (es)
AT (1) AT398572B (es)
AU (1) AU593244B2 (es)
BE (1) BE904724A (es)
CA (1) CA1278792C (es)
CH (1) CH672787A5 (es)
DE (1) DE3615180C2 (es)
DK (1) DK165745C (es)
EG (1) EG18206A (es)
ES (6) ES8801250A1 (es)
FI (1) FI85484C (es)
FR (1) FR2581385B1 (es)
GB (1) GB2174703B (es)
GR (1) GR861149B (es)
HU (1) HU195509B (es)
IE (1) IE59201B1 (es)
IT (1) IT1208607B (es)
LU (1) LU86421A1 (es)
MY (1) MY100777A (es)
NL (1) NL8601146A (es)
PT (1) PT82523B (es)
SE (1) SE465270B (es)
ZA (1) ZA862046B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5801186A (en) 1987-11-20 1998-09-01 Hoechst Marion Roussel, Inc. 3- 4-(1-substituted-4-piperazinyl)butyl!-4-thiazolidinone and related compounds
US4880930A (en) * 1987-11-30 1989-11-14 New James S Psychotropic acyclic amide derivatives
US4780466A (en) * 1988-03-17 1988-10-25 Hoechst-Roussel Pharmaceuticals, Inc. Arylpiperazinylalkoxy derivatives of cyclic imides
IE903410A1 (en) * 1989-10-09 1991-04-10 Novo Nordisk As Indole derivatives, their preparation and use
US5272148A (en) * 1992-09-09 1993-12-21 Hoechst-Roussel Pharmaceuticals Incorporated Heteroarenylpiperazines
BR9610579A (pt) * 1995-09-15 1999-07-06 Sanofi Synthelabo Derivados de quinolein-2(1H)-ona como antagonistas da serotonina
FR2738822B1 (fr) * 1995-09-15 1997-10-31 Synthelabo Derives de 4-(omega-(4-(thieno(3,2-c)pyridin-4-yl)piperazin- 1-yl)alkyl)quinolein-2(1h)-one, leur preparation et leur application en therapeutique
FR2738824B1 (fr) * 1995-09-15 1997-10-31 Synthelabo Derives de 3-(omega(4-(thieno(3,2-c)pyridin-4-yl)piperazin-1 -yl)alkyl)-3,4-dihydroquinazolin-2(1h)-one,leur preparation et leur application en therapeutique
FR2738823B1 (fr) * 1995-09-15 1997-10-31 Synthelabo Derives de 3-(omega-(4-(thieno(3,2-c)pyridin-4-yl)piperazin- 1-yl)alkyl)-3,4-dihydroquinolein-2(1h)-one,leur preparation et leur application en therapeutique
FR2761071B1 (fr) * 1997-03-20 1999-12-03 Synthelabo Derives de quinolein-2(1h)-one et de dihydroquinolein-2(1h)- one, leur preparation et leur application en therapeutique
FR2797874B1 (fr) * 1999-08-27 2002-03-29 Adir Nouveaux derives de la pyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4367335A (en) * 1981-08-03 1983-01-04 Mead Johnson & Company Thiazolidinylalkylene piperazine derivatives
US4452799A (en) * 1981-12-23 1984-06-05 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
US4361565A (en) * 1981-12-28 1982-11-30 Mead Johnson & Company 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyridines

Also Published As

Publication number Publication date
GB2174703B (en) 1988-10-26
FI861820A0 (fi) 1986-04-30
AT398572B (de) 1994-12-27
FR2581385A1 (fr) 1986-11-07
FI861820A (fi) 1986-11-07
ES8802614A1 (es) 1988-09-01
NL8601146A (nl) 1986-12-01
ZA862046B (en) 1986-11-26
ES9000005A1 (es) 1989-11-01
DK207186A (da) 1986-11-07
IE861193L (en) 1986-11-06
ES557839A0 (es) 1989-01-16
CN86103071A (zh) 1987-03-18
SE8602061L (sv) 1986-11-07
JPH0753728B2 (ja) 1995-06-07
DK207186D0 (da) 1986-05-05
FI85484C (fi) 1992-04-27
HUT43848A (en) 1987-12-28
HU195509B (en) 1988-05-30
GR861149B (en) 1986-09-09
EG18206A (en) 1992-09-30
ES8801250A1 (es) 1987-12-16
IE59201B1 (en) 1994-01-26
KR940000829B1 (ko) 1994-02-02
CH672787A5 (es) 1989-12-29
ES8802149A1 (es) 1988-04-01
DK165745C (da) 1993-06-14
CN1017901B (zh) 1992-08-19
ES554659A0 (es) 1987-12-16
ATA121486A (de) 1994-05-15
PT82523B (pt) 1988-10-14
DE3615180C2 (de) 1996-03-07
ES557809A0 (es) 1988-09-01
DK165745B (da) 1993-01-11
AU5679586A (en) 1986-11-13
ES8900138A1 (es) 1989-01-16
PT82523A (en) 1986-06-01
DE3615180A1 (de) 1986-11-06
IT1208607B (it) 1989-07-10
MY100777A (en) 1991-02-14
JPS61268681A (ja) 1986-11-28
AU593244B2 (en) 1990-02-08
ES557757A0 (es) 1988-04-01
IT8620313A0 (it) 1986-05-06
ES8900253A1 (es) 1989-05-16
CA1278792C (en) 1991-01-08
FR2581385B1 (fr) 1991-10-04
GB2174703A (en) 1986-11-12
BE904724A (fr) 1986-11-05
ES557855A0 (es) 1989-05-16
SE8602061D0 (sv) 1986-05-05
FI85484B (fi) 1992-01-15
GB8610810D0 (en) 1986-06-11
KR860009008A (ko) 1986-12-19
SE465270B (sv) 1991-08-19

Similar Documents

Publication Publication Date Title
CH620925A5 (es)
FR2555585A1 (fr) Derives de la 1-heteroaryl-4 ((2,5-pyrrolidinedion-1-yl) alkyl )piperazine, leur procede de preparation et leur application pharmacologique
JPH054983A (ja) イソキノリノン誘導体、その製造方法およびその誘導体を有効成分として含有する５−ｈｔ３ レセプター拮抗剤
KR20130046436A (ko) 안드로겐 수용체 길항제, 항암제로서 사이클릭 n,n''-다이아릴티오우레아 및 n,n''-다이아릴우레아, 이의 제조방법 및 이의 용도
JPH02290841A (ja) 新規化合物、その製法及びそれを含む医薬組成物
LU86421A1 (fr) Derives de piperazine 1,4-disubstitues,composition pharmaceutique les contenant;leur procede d'obtention
FR2846657A1 (fr) Nouveaux composes pyridopyrimidinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2489823A1 (fr) Nouvelles n-((4-(3-pyridyle substitue en position 3)-piperazino)alkyl)azaspirodecanediones, leur procede de preparation et medicament les contenant
JPH01168677A (ja) 向精神性非環式アミド誘導体
FR2684672A1 (fr) Derives de pyrimidine, utiles pour le traitement d'etats tels que l'hypertension et l'insuffisance cardiaque, et procede pour leur preparation.
US5049637A (en) 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino-[1,2-a]azepino derivatives and 10-aza, 10-oxa and 10-thia analogues
FR2580282A1 (fr) Derives a cycle imidique de 2-(4-butylpiperazine-1-yl)pyridines et leur application antipsychotique
US4677104A (en) Antipsychotic fused-ring pyridinylpiperazine derivatives
FR2532937A1 (fr) Nouveaux derives de thiadiazolyl-s-oxyde, procede pour leur preparation et compositions pharmaceutiques les comportant
LU86405A1 (fr) Derive antipsychotique du benzisothiazole s-oxyde
FR2510571A1 (fr) Spirothiazolidinedione, son procede de production et preparation pharmaceutique la contenant
US20060094764A1 (en) Cyanothiophenes, their preparation and their use in pharmaceutical compositions
IE902290L (en) (1,2,3,4-Tetrahydro-9-acridinimino) cyclohexane carboxylic¹acid and related compounds, a process for their preparation¹and their use as medicaments
CA2346506C (fr) Derives d'aryl-{4-fluoro-4-[(2-pyridin-2-yl-ethylamino)-methyl]-piperidin-1-yl}-methanone comme agonistes du recepteur 5-ht1
JP4560259B2 (ja) ベンズイミダゾール化合物及びそれを含む医薬
WO1999002527A1 (fr) Derives de naphthyridine
LU82950A1 (fr) 1-oxo-1h-thiazolo-(3,2-a)-pyrimidine-2-carboxamides,anti-allergiques et anti-ulcereux,medicament les contenant et composes intermediaires permettant de les obtenir
JPS59205384A (ja) ヒダントイン誘導体
CN111662239B (zh) 1,2,4-三唑类化合物及其制法和药物用途
CN116535361A (zh) 取代羟基嘧啶类黄嘌呤氧化酶抑制剂及其制法和药物用途

Legal Events

Date Code Title Description
DT Application date
TA Annual fee